Hap Trading, LLC Vir Biotechnology, Inc. Call Options Transaction History

Hap Trading, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	BUY	$19.96 - $28.22 $1,996 - $2,822	100 Added 0.45%	22,300 $5,000
Q3 2022 Nov 14, 2022	BUY	$18.26 - $31.1 $125,994 - $214,590	6,900 Added 45.1%	22,200 $9,000
Q2 2022 Aug 12, 2022	BUY	$19.08 - $26.7 $49,607 - $69,420	2,600 Added 20.47%	15,300 $20,000
Q1 2022 May 12, 2022	BUY	$21.19 - $40.01 $23,309 - $44,011	1,100 Added 9.48%	12,700 $15,000
Q4 2021 Feb 14, 2022	BUY	$30.97 - $54.03 $359,252 - $626,748	11,600 New	11,600 $50,000
Q1 2021 May 14, 2021	SELL	$26.34 - $83.07 $287,106 - $905,462	-10,900 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$25.51 - $43.38 $278,059 - $472,842	10,900 New	10,900 $8,000

218

87M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $982M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.